Amy Steffen
Impact in
-
- Diabetes Management and Research
- Diabetes Treatment and Management
- Hyperglycemia and glycemic control in critically ill and hospitalized patients
- Diabetes Management and Education
- Genetics top 10%
- Diabetes and associated disorders
Papers in
-
- Diabetes Management and Research 17
- Hyperglycemia and glycemic control in critically ill and hospitalized patients 2
- Diabetes Treatment and Management 1
- Surgery 7
- Pancreatic function and diabetes 7
- Co-authors
- William V. Tamborlane (19 shared papers)Stuart A. Weinzimer (14 shared papers)Elizabeth A. Doyle (3 shared papers)Jo Ann Ahern (1 shared paper)James Dziura (4 shared papers)J. Ahern (2 shared papers)Karena Swan (5 shared papers)Garry M. Steil (3 shared papers)
- Journals
- Diabetes Care (5 papers)Diabetes Technology & Therapeutics (3 papers)Reviews in Endocrine and Metabolic Disorders (1 paper)The Journal of Pediatrics (1 paper)Diabetes (1 paper)
- Partner nations
- United StatesGermany
In The Last Decade
Amy Steffen
20 papers receiving 776 citations
Peers
Comparison fields: 5 of 50
- Endocrinology, Diabetes and Metabolism 715
- Genetics 273
- Surgery 316
- Pharmaceutical Science 12
- Speech and Hearing 6
Countries citing papers authored by Amy Steffen
This map shows the geographic impact of Amy Steffen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Amy Steffen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Amy Steffen more than expected).
Fields of papers citing papers by Amy Steffen
This network shows the impact of papers produced by Amy Steffen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Amy Steffen. The network helps show where Amy Steffen may publish in the future.
Co-authors
The 25 scholars most cited alongside Amy Steffen, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2004 | 268 | |
| 2 | 2004 | 133 | |
| 3 | 2006 | 80 | |
| 4 | 2008 | 70 | |
| 5 | 2009 | 53 | |
| 6 | 2007 | 50 | |
| 7 | 2013 | 26 | |
| 8 | 2003 | 25 | |
| 9 | 2013 | 25 | |
| 10 | 2006 | 18 | |
| 11 | 2012 | 17 | |
| 12 | 2007 | 16 | |
| 13 | 2005 | 14 | |
| 14 | 2006 | 13 | |
| 15 | 2005 | 6 | |
| 16 | 2023 | 4 | |
| 17 | 2019 | 2 | |
| 18 | 2021 | 1 | |
| 19 | 2018 | 1 | |
| 20 | 2013 | 1 |
About Amy Steffen
Amy Steffen is a scholar working on Endocrinology, Diabetes and Metabolism, Surgery, Genetics, Pharmacology and Pediatrics, Perinatology and Child Health, having authored 20 papers that have together received 823 indexed citations. Recurring topics across this work include Diabetes Management and Research (17 papers), Pancreatic function and diabetes (7 papers), Diabetes and associated disorders (5 papers), Hyperglycemia and glycemic control in critically ill and hospitalized patients (2 papers), Pharmaceutical studies and practices (1 paper), Diabetes Treatment and Management (1 paper) and Cannabis and Cannabinoid Research (1 paper). The work is most often cited by research in Endocrinology, Diabetes and Metabolism (715 citations), Genetics (273 citations), Surgery (316 citations), Pharmaceutical Science (12 citations) and Speech and Hearing (6 citations). Amy Steffen has collaborated with scholars based in United States and Germany. Frequent co-authors include William V. Tamborlane, Stuart A. Weinzimer, Elizabeth A. Doyle, Jo Ann Ahern, James Dziura, J. Ahern, Karena Swan, Garry M. Steil, Eda Cengiz and Gayane Voskanyan. Their work appears in journals such as Diabetes Care, Diabetes Technology & Therapeutics, Reviews in Endocrine and Metabolic Disorders, The Journal of Pediatrics and Diabetes.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.